NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹346 Cr | ₹401 Cr | ₹216 Cr | ₹82 Cr | ₹105 Cr |
What is the latest Profit Before Tax of NEULAND LABORATORIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹401 Cr |
| Mar2023 | ₹216 Cr |
| Mar2022 | ₹82 Cr |
| Mar2021 | ₹105 Cr |
How is Profit Before Tax of NEULAND LABORATORIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹346 Cr | -13.73 | |
| Mar2024 | ₹401 Cr | 86.07 | |
| Mar2023 | ₹216 Cr | 162.58 | |
| Mar2022 | ₹82 Cr | -22.00 | |
| Mar2021 | ₹105 Cr | - | |
Compare Profit Before Tax of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,392.7 Cr | -6.2% | -3.3% | 20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -6.2% |
-3.3% |
20.1% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses